Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Chromosome 17 deletion × ixazomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 24 Waldenstrom Macroglobulinemia 3 Immunoglobulin Light-chain Amyloidosis 3 Recurrence 2 Lymphoma, Mantle-Cell 2 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Proteostasis Deficiencies 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Carcinoma, Transitional Cell 1 Amyloidosis 1

Interventions

pomalidomide 2 fludarabine phosphate 2 Dexamethasone 2 venetoclax 1 pembrolizumab 1 ibrutinib 1 fludarabine 1 daratumumab 1 acalabrutinib 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡